These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3320083)

  • 21. Antibiotic susceptibilities of Serratia marcescens and Enterobacter liquefaciens.
    Greenup P; Blazevic DJ
    Appl Microbiol; 1971 Sep; 22(3):309-14. PubMed ID: 4330312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
    Ramadan MA; Tawfik AF; Shibl AM
    Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outer membrane protein alterations in Serratia marcescens resistant against aminoglycoside and beta-lactam antibiotics.
    Traub WH; Bauer D
    Chemotherapy; 1987; 33(3):172-6. PubMed ID: 3297527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased susceptibility of Serratia marcescens to chlorhexidine related to the inner membrane.
    Lannigan R; Bryan LE
    J Antimicrob Chemother; 1985 May; 15(5):559-65. PubMed ID: 3891711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
    Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [O-serotypes, biochemical properties and antimicrobial susceptibility of Serratia marcescens isolates from clinical specimens].
    Marumo K; Aoki Y; Takeuchi T
    Rinsho Byori; 1987 May; 35(5):555-60. PubMed ID: 2441093
    [No Abstract]   [Full Text] [Related]  

  • 27. [Epidemiological evaluation of Serratia marcescens isolates in one Japanese hospital during the two years from April 1997 to March 1999].
    Marumo K; Nakamura Y; Togashi M
    Rinsho Byori; 2000 Oct; 48(10):960-5. PubMed ID: 11215111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmid prevalence in antibiotic resistant Serratia marcescens.
    Llanes C; Michel-Briand Y; Bailly C; Grimont F
    J Chemother; 1989 Jul; 1(4 Suppl):311-2. PubMed ID: 16312416
    [No Abstract]   [Full Text] [Related]  

  • 29. [Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
    Kawakami Y; Okimura Y; Horiuchi N; Kanai M
    Jpn J Antibiot; 1982 Sep; 35(9):2314-7. PubMed ID: 6292543
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.
    Markowitz SM; Sibilla DJ
    Antimicrob Agents Chemother; 1980 Nov; 18(5):651-5. PubMed ID: 7004344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteriocin typing of Serratia marcescens isolates of known serotype-group.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):979-81. PubMed ID: 4555640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic resistance and putative virulence factors of Serratia marcescens with respect to O and K serotypes.
    Aucken HM; Pitt TL
    J Med Microbiol; 1998 Dec; 47(12):1105-13. PubMed ID: 9856647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific distribution of R factors in Serratia marcescens strains isolated from hospital infections.
    Schaefler S; Winter J; Catelli A; Greene J; Toharski B
    Appl Microbiol; 1971 Sep; 22(3):339-43. PubMed ID: 4940874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osmotic properties of spheroplasts from Saccharomyces cerevisiae grown at different temperatures.
    Diamond RJ; Rose AH
    J Bacteriol; 1970 May; 102(2):311-9. PubMed ID: 4986757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].
    Schmid B; Kayser FH
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on serotyping, phage typing and drug resistance of Serratia marcescens isolated from clinical specimens (author's transl)].
    Morishita H
    Nihon Hinyokika Gakkai Zasshi; 1980 Nov; 71(11):1313-27. PubMed ID: 7007698
    [No Abstract]   [Full Text] [Related]  

  • 37. Light and electron microscopy of the morphological response of Escherichia coli and Serratia marcescens to cefmenoxime (SCE-1365), a new broad-spectrum cephalosporin.
    Nakao M; Kondo M; Tsuchiya K
    J Antibiot (Tokyo); 1981 Aug; 34(8):1046-54. PubMed ID: 6274836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity.
    Młynarczyk A; Młynarczyk G; Pupek J; Bilewska A; Kawecki D; Łuczak M; Gozdowska J; Durlik M; Paczek L; Chmura A; Rowińnski W
    Transplant Proc; 2007 Nov; 39(9):2879-82. PubMed ID: 18022007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapy.
    Hemarajata P; Amick T; Yang S; Gregson A; Holzmeyer C; Bush K; Humphries RM
    J Antimicrob Chemother; 2018 May; 73(5):1256-1262. PubMed ID: 29471486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta-Lactam resistance in Serratia marcescens: comparison of action of benzylpenicillin, Apalcillin, Cefazolin, and ceftizoxime.
    Takata N; Suginaka H; Kotani S; Ogawa M; Kosaki G
    Antimicrob Agents Chemother; 1981 Mar; 19(3):397-401. PubMed ID: 7018390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.